Although low dose aspirin reduces risk in patients with heart disease, many such patients do
not receive daily prophylactic aspirin. 1 We report a trial of feedback of general practitioners' …

Don’t use aspirin for primary prevention of cardiovascular disease | The BMJ Skip to main
content Intended for healthcare professionals Access provided by Google Indexer Subscribe …

The use of aspirin and other antiplatelet agents has sky rocketed in the past decade as the
indications have widened to include primary and secondary prevention of myocardial and …

Our previous study found that less than a fifth of patients admitted to hospital with suspected
acute myocardial infarction had been given aspirin by their general practitioner before their …

The Antiplatelet Trialists' Collaboration provided convincing evidence of benefits of aspirin
prophylaxis in patients after myocardial infarction, 1 but many such patients do not receive it …

Aspirin is an old drug. Some 2000 years ago the Greeks used the bark and leaves of the
willow tree (which contains salicylic acid) to relieve pain and fever. At the end of the 19th …

On p 71 we publish the latest in a series of meta-analyses from the Antithrombotic Trialists'
Collaboration. Here John Cleland argues that, despite the vast size of these meta-analyses …

Aspirin is a highly effective antiplatelet agent that is used by millions of people to reduce
cardiovascular morbidity and mortality. 1 2 However, a recent pharmacodynamic study …

Editor—The worldwide meta-analysis of antiplatelet trials shows that low dose aspirin (or
some other effective antiplatelet regimen) reduces non-fatal myocardial infarction, nonfatal …

Low dose aspirin has been shown to reduce the risk of myocardial infarction and thrombotic
stroke in patients at high risk of vascular death. Does aspirin work in diabetic patients? Is the …